Clinical signs and symptoms predicting influenza infection

Archives of Internal Medicine

Volumn 160, Issue 21, 2000, Pages 3243-3247

  Monto, A S ^a   Gravenstein, S ^a   Elliott, M ^a   Colopy, M ^a   Schweinle, J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; FEMALE; FEVER; HUMAN; INFLUENZA; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NOSE CONGESTION; PHASE 2 CLINICAL TRIAL; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL;

EID: 0034722740     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.160.21.3243     Document Type: Article

References (28)

1. Economic impact of influenza: The individual's perspective
2. Influenza: Quantifying morbidity and mortality
3. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections: The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group
4. Clinical manifestations and consequences of influenza
5. Medical practice-based influenza surveillance: Viral prevalence and assessment of morbidity
6. Studies of the community and family: Acute respiratory illness and infection
7. Influenza and influenza-like illness in general practice: Drawing lessons for surveillance from a pilot study in Paris, France
8. Influenza surveillance in communitydwelling elderly compared with children
9. Influenza control - Unfinished business
10. Underused options for preventing and treating influenza
11. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza
12. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza virus infections
13. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection
14. Emergence and transmission of influenza A viruses resistant to amantadine and rimantadine
15. Emergence and possible transmission of amantadine-resistant viruses during nursing home outbreaks of influenza A (H3N2)
16. Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: Randomized controlled trials for prevention and treatment
17. The diagnosis and management of influenza: An update
18. Influenza virus pneumonia: Pathogenesis, treatment, and prevention
19. Prospective application of reverse transcriptase polymerase chain reaction for diagnosing influenza infections in respiratory samples from a children's hospital
20. Rapid viral diagnosis of acute respiratory infections: Comparison of enzyme-linked immunosorbent assay and the immunofluorescence technique for detection of viral antigens in nasopharyngeal secretions
21. The evolving epidemiology of influenza infection and disease
22. Evaluation of clinical case definitions of influenza: Detailed investigation of patients during the 1995-1996 epidemic in France
23. Acute viral infections of upper respiratory tract in elderly people living in the community: Comparative, pro-spective, population based study of disease burden
24. Can respiratory syncytial virus and influenza A be distinguished clinically in institutionalized older persons?
25. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections
26. The efficacy and safety of inhaled zanamivir in the treatment of influenza in otherwise healthy and 'high risk' individuals in North America [abstract]
27. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: A randomized, double-blind, placebo-controlled European study